Fighting cancer by inhibiting desuccinylation of metabolic enzymes

Succinylation and malonylation as novel protein modifications in cancer

Image shows a sirtuin enzyme catalyzing the removal of a protein modification (lysine succinylation) from metabolic enzymes. This activity is required for the malignant growth of cancer cells. Small molecule inhibitors of the desuccinylation process may be a novel way to treat cancer.